Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in Plasma
Yu‐Min Kuo(National Yang Ming Chiao Tung University), Alex E. Roher(Barrow Neurological Institute), Walter M. Kalback(Banner Sun Health Research Institute), Douglas Galasko(University of Minnesota), Tyler A. Kokjohn(Midwestern University), Edward H. Koo(National University of Singapore), Nathalie Chevallier(University of California, San Diego), Mark R. Emmerling, Dean C. Luehrs(Banner Sun Health Research Institute)
Cited by 226
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
|American Journal Of Pathology|1999|1.5k
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
|Journal of Biological Chemistry|1993|799
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
|Neurology|2020|772